The impact of respite care from the perspectives and experiences of people with amyotrophic lateral sclerosis and their care partners: a qualitative study.


Journal

BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685

Informations de publication

Date de publication:
28 Feb 2022
Historique:
received: 17 06 2021
accepted: 16 02 2022
entrez: 1 3 2022
pubmed: 2 3 2022
medline: 3 3 2022
Statut: epublish

Résumé

Respite care provides caregiving support to people with amyotrophic lateral sclerosis (ALS) and their care partners by providing the care partner with temporary relief from their caregiving duties. The aim of this study was to explore the impact of respite care through the perspectives and lived experiences of people with ALS and their care partners. Thirty-one dyads (62 participants) of people with ALS and their care partners were assigned to either the control group or the respite care intervention. Respite care was provided in the form of home-based services. Semi-structured interviews were conducted with participants at baseline and after a six-month period to gather perspectives on ALS caregiving, perceptions of respite care, and the respite care experience. Interviews were transcribed and subjected to thematic analysis. Caregiving challenges specific to the care partner and the patient-care partnership relationship were identified. Overall, people with ALS and care partners responded positively to in-home respite care and reported improved relationship quality, more time for the care partner to pursue personal commitments or take a break, and improved emotional well-being for both the person with ALS and the care partner. Barriers and concerns were raised surrounding privacy and staff consistency. This study highlights respite care as a critical tool to alleviate caregiving challenges and support the needs of people with ALS and their care partners. Engagement with the ALS community and formal evaluations of respite care services should be prioritized in order to minimize barriers and best meet the needs of people with ALS and their care partners.

Sections du résumé

BACKGROUND BACKGROUND
Respite care provides caregiving support to people with amyotrophic lateral sclerosis (ALS) and their care partners by providing the care partner with temporary relief from their caregiving duties. The aim of this study was to explore the impact of respite care through the perspectives and lived experiences of people with ALS and their care partners.
METHODS METHODS
Thirty-one dyads (62 participants) of people with ALS and their care partners were assigned to either the control group or the respite care intervention. Respite care was provided in the form of home-based services. Semi-structured interviews were conducted with participants at baseline and after a six-month period to gather perspectives on ALS caregiving, perceptions of respite care, and the respite care experience. Interviews were transcribed and subjected to thematic analysis.
RESULTS RESULTS
Caregiving challenges specific to the care partner and the patient-care partnership relationship were identified. Overall, people with ALS and care partners responded positively to in-home respite care and reported improved relationship quality, more time for the care partner to pursue personal commitments or take a break, and improved emotional well-being for both the person with ALS and the care partner. Barriers and concerns were raised surrounding privacy and staff consistency.
CONCLUSION CONCLUSIONS
This study highlights respite care as a critical tool to alleviate caregiving challenges and support the needs of people with ALS and their care partners. Engagement with the ALS community and formal evaluations of respite care services should be prioritized in order to minimize barriers and best meet the needs of people with ALS and their care partners.

Identifiants

pubmed: 35227242
doi: 10.1186/s12904-022-00919-2
pii: 10.1186/s12904-022-00919-2
pmc: PMC8886844
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

26

Informations de copyright

© 2022. The Author(s).

Références

BMJ Open. 2018 Jan 27;8(1):e018721
pubmed: 29374665
Int Psychogeriatr. 2003 Mar;15(1):37-58
pubmed: 12834199
Res Nurs Health. 2000 Aug;23(4):334-40
pubmed: 10940958
BMC Geriatr. 2017 Dec 7;17(1):282
pubmed: 29216836
Glob Qual Nurs Res. 2017 Nov 24;4:2333393617742282
pubmed: 29204457
BMC Palliat Care. 2016 Sep 05;15(1):81
pubmed: 27596749
Res Nurs Health. 2010 Feb;33(1):77-84
pubmed: 20014004
Qual Life Res. 2011 Jun;20(5):703-11
pubmed: 21127997
Gerontologist. 2001 Aug;41(4):462-73
pubmed: 11490044
BMC Palliat Care. 2020 Mar 25;19(1):40
pubmed: 32213170
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Int J Palliat Nurs. 2017 Apr 2;23(4):174-185
pubmed: 28486069
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):9-14
pubmed: 23781974
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Disabil Rehabil. 2012;34(3):247-56
pubmed: 22087569
Palliat Support Care. 2019 Apr;17(2):195-201
pubmed: 29397051
Inquiry. 2018 Jan-Dec;55:46958017751507
pubmed: 29424252
J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
Int J Geriatr Psychiatry. 2016 Dec;31(12):1277-1288
pubmed: 27245986
Contemp Nurse. 2012 Apr;41(1):111-9
pubmed: 22724912
Gerontologist. 1980 Dec;20(6):649-55
pubmed: 7203086
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):292-7
pubmed: 24555470
Surg Neurol Int. 2015 Nov 16;6:171
pubmed: 26629397
Arch Public Health. 2018 Nov 22;76:72
pubmed: 30479766
J Cent Nerv Syst Dis. 2019 Jul 08;11:1179573519859360
pubmed: 31312086
Psychol Med. 2006 Jun;36(6):865-75
pubmed: 16490122
J Pain Symptom Manage. 2003 Oct;26(4):890-6
pubmed: 14527757

Auteurs

Julia M Wu (JM)

Department of Medicine, Division of Neurology, The University of British Columbia, Vancouver, BC, Canada.
BC Children's & Women's Hospital, 4480 Oak Street, Room B402 Shaughnessy, Vancouver, BC, V6H 3N1, Canada.

Mallorie T Tam (MT)

Department of Medicine, Division of Neurology, The University of British Columbia, Vancouver, BC, Canada.
BC Children's & Women's Hospital, 4480 Oak Street, Room B402 Shaughnessy, Vancouver, BC, V6H 3N1, Canada.

Kirsten Buch (K)

ALS Society of BC, Vancouver, BC, Canada.

Fouziah Khairati (F)

ALS Society of BC, Vancouver, BC, Canada.

Laurissa Wilson (L)

ALS Society of BC, Vancouver, BC, Canada.

Elizabeth Bannerman (E)

ALS Society of BC, Vancouver, BC, Canada.

Alexandra Guerrero (A)

ALS Society of BC, Vancouver, BC, Canada.

Andrew Eisen (A)

Department of Medicine, Division of Neurology, The University of British Columbia, Vancouver, BC, Canada.

Wendy Toyer (W)

ALS Society of BC, Vancouver, BC, Canada.

Travis Stevenson (T)

ALS Society of BC, Vancouver, BC, Canada.

Julie M Robillard (JM)

Department of Medicine, Division of Neurology, The University of British Columbia, Vancouver, BC, Canada. jrobilla@mail.ubc.ca.
BC Children's & Women's Hospital, 4480 Oak Street, Room B402 Shaughnessy, Vancouver, BC, V6H 3N1, Canada. jrobilla@mail.ubc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH